[Federal Register Volume 66, Number 206 (Wednesday, October 24, 2001)]
[Notices]
[Page 53786]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-26719]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant Exclusive Patent License; Acambis, Inc.

AGENCY: Department of the Navy, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Acambis, Inc., a revocable, nonassignable, exclusive 
license to practice worldwide the Government-owned inventions described 
in U.S. Patent application Serial No. 09/439,311, entitled ``A 
Recombinant Polypeptide for Use in the Manufacture of Vaccines Against 
Campylobacter Induced Diarrhea and to Reduce Colonization'' filed 
November 14, 1998, and its PCT serial number US99/27195 in the field of 
vaccines against Campylobacter associated disease.

DATES: Anyone wishing to object to the grant of this license has 
fifteen (15) days from the date of this notice to file written 
objections along with supporting evidence, if any.

ADDRESSES: Written objections are to be filed with the Office of 
Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500, telephone (301) 319-7428.

    Dated: October 15, 2001.
T.J. Welsh,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
[FR Doc. 01-26719 Filed 10-23-01; 8:45 am]
BILLING CODE 3810-FF-P